How do I solubilize a research peptide?
Dissolve the peptide in a small volume of an appropriate solvent, then dilute to working concentration. Start with sterile water or dilute aqueous buffer for hydrophilic sequences. Hydrophobic or aggregation-prone peptides often require a small amount of a stronger solvent first, such as DMSO, dilute acetic acid for basic peptides, or dilute ammonium hydroxide for acidic peptides, before aqueous dilution. Sonication and gentle warming aid dispersion. Always prepare fresh, avoid repeated freeze-thaw, and test a small aliquot before dissolving the full lot.
How do I know if my peptide will be soluble?
Estimate solubility from sequence charge, hydrophobicity, and isoelectric point before dissolving. Count acidic (Asp, Glu) and basic (Arg, Lys, His) residues: a net charge at neutral pH generally improves aqueous solubility. Sequences rich in hydrophobic residues (Leu, Ile, Val, Phe, Ala) or greater than about 50 percent hydrophobic content tend to aggregate. Peptides whose net charge is near zero, meaning pH at or close to the pI, are least soluble and may need a charged buffer above or below that pI.
What is the difference between net (peptide content) and gross peptide weight?
Gross weight is the total mass of the supplied powder; net peptide content is the fraction of that mass that is actual peptide. The remainder is bound water, counterions, and residual salts, typically 10 to 30 percent of gross weight. Peptide content is determined by amino acid analysis or nitrogen analysis. When preparing a precise molar solution, weigh by gross mass but correct for peptide content so the true peptide concentration matches the intended target.
What is the difference between peptide content and peptide purity?
Purity describes what fraction of the peptide present is the correct target sequence, while content describes how much actual peptide is in the powder. A lot can be 95 percent pure by HPLC yet only 75 percent peptide content by weight, because purity ignores non-peptide mass like water and counterions. Purity is measured by analytical HPLC; content is measured by amino acid analysis. Both values are reported separately on a certificate of analysis.
How do I calculate the molarity of a peptide solution?
Use molarity = mass / (molecular weight x volume), then adjust for peptide content. For example, 1 mg of a peptide with MW 1000 g/mol in 1 mL gives 1 mmol / 1000 g x 0.001 g / 0.001 L = 0.001 mol/L, or 1 mM. If peptide content is 80 percent, multiply the effective mass by 0.80, yielding 0.8 mM. Always use the salt-corrected MW when the counterion contributes significant mass.
What is a peptide counterion and why does it matter?
A counterion is the charged species that balances a peptide's net charge in the solid salt form, most often trifluoroacetate (TFA) from purification or acetate after a salt exchange. TFA can interfere with sensitive cell-based and biological assays, so acetate or hydrochloride salts are preferred for those applications. The counterion adds mass and affects net peptide content. Certificates report the salt form so researchers can correct concentration and select an assay-compatible counterion.
How is peptide purity determined by HPLC?
Analytical reversed-phase HPLC separates the target peptide from synthesis impurities, and purity is the target peak area as a percentage of total integrated peak area. A C18 column with a water/acetonitrile gradient containing 0.1 percent TFA is standard, with UV detection at 214 nm for the peptide bond or 280 nm for aromatic residues. Deletion sequences, truncations, and oxidized forms appear as resolved peaks. A single sharp dominant peak indicates high purity.
What is mass spectrometry and why is it used in peptide QC?
Mass spectrometry measures the molecular mass of a peptide to confirm the correct sequence was synthesized. It ionizes the peptide and measures the mass-to-charge ratio, so the observed mass can be compared with the calculated theoretical mass. MALDI is robust for crude or single-charge analysis and tolerates salts well, while ESI produces multiply charged ions suited to high-resolution and LC coupling. A mass matching theory within a few mass units confirms identity alongside HPLC purity.
What do the M+Na and M+K mass peaks in a MALDI spectrum mean?
They are sodium and potassium adducts of the peptide, not impurities or wrong sequences. In MALDI, a peptide commonly ionizes as the protonated molecule [M+H]+, but it can also bind sodium or potassium from residual salts, appearing at M+22 (sodium replacing a proton, +23 minus 1) and M+38 (potassium, +39 minus 1) relative to [M+H]+. Recognizing these satellite peaks prevents misreading them as modifications. Desalting reduces adduct intensity.
Should the N- and C-termini of a peptide be capped?
Capping is often used to mimic the native protein environment and improve stability. N-terminal acetylation neutralizes the positive alpha-amino charge, and C-terminal amidation neutralizes the negative carboxylate, together making a fragment more closely resemble an internal segment of the parent protein. Capping also reduces exopeptidase degradation and can improve receptor binding. For antibody production and structure studies capping is common, though free termini are retained when the natural charge state is required.
What is a cyclized peptide and how is cyclization confirmed?
A cyclized peptide has a covalent bond joining two points in the chain, forming a ring that constrains conformation and improves stability. Common types include head-to-tail (N to C), side-chain to side-chain, and disulfide bridges between cysteine residues. Cyclization is confirmed by mass spectrometry, since ring closure removes mass: a disulfide bond shows a 2 Da loss from the two thiol hydrogens, and a lactam shows loss of water (18 Da). Ellman's reagent can verify absence of free thiols.
What does "orthogonal protection" mean for disulfide-bridge cyclization?
Orthogonal protection means using cysteine protecting groups that are removed under different, independent conditions so multiple disulfides form in a defined order. In peptides with two or more bridges, pairing the wrong cysteines gives the wrong isomer, so each pair is protected with groups like Trt, Acm, or tBu that are cleaved selectively. The first bridge is formed and oxidized, then a second protecting group is removed and its bridge closed. This regioselective approach yields the correct disulfide connectivity.
What is a biotinylated peptide and what spacer is commonly used?
A biotinylated peptide carries a covalently attached biotin group for high-affinity capture by streptavidin or avidin in assays such as ELISA, pull-downs, and immobilization. Biotin is usually coupled at the N-terminus or to a lysine side chain. A spacer arm is added between biotin and the peptide to reduce steric hindrance and improve streptavidin access; aminohexanoic acid (Ahx, a six-carbon spacer) is the most common, and short PEG spacers are also used. The spacer markedly improves binding efficiency.
What is a pyroglutamyl peptide?
A pyroglutamyl peptide carries pyroglutamate, a cyclized residue formed at the N-terminus from glutamine or glutamic acid. The free alpha-amino group condenses with the side-chain carbonyl to form a five-membered lactam ring (pyroglutamic acid, pGlu), blocking the N-terminus. This occurs naturally in many bioactive peptides and can also form spontaneously during synthesis or storage. Because it caps the amino terminus, a pyroglutamyl group confers resistance to aminopeptidases and prevents standard Edman N-terminal sequencing.
How are peptides conjugated to a carrier protein?
Short peptides are coupled to a large carrier protein such as KLH or BSA to make them immunogenic for antibody production. A bifunctional crosslinker links a reactive group on the peptide to a complementary group on the carrier: glutaraldehyde bridges amines, MBS or SMCC link a cysteine thiol to carrier lysines, and carbodiimide (EDC) couples carboxyls to amines. An extra terminal cysteine is often added to give a defined, oriented attachment point. KLH is preferred for immunization and BSA for screening.
What chemistry is used to synthesize peptides?
Most research peptides are made by Fmoc solid-phase peptide synthesis (SPPS), building the chain stepwise on an insoluble resin. The growing peptide is anchored to resin and extended one residue at a time from the C-terminus toward the N-terminus. Each cycle removes the base-labile Fmoc protecting group with piperidine, then couples the next Fmoc-amino acid using activators such as HBTU or DIC/Oxyma. After assembly, TFA cleaves the peptide from resin and removes side-chain protecting groups simultaneously.
What QC testing is standard for research-grade peptides?
Identity and purity are confirmed by HPLC and mass spectrometry, supplemented by content and counterion data. Analytical reversed-phase HPLC reports purity as percent target peak area, and MALDI or ESI mass spectrometry confirms the molecular mass matches theory. Amino acid analysis quantifies peptide content, and the salt or counterion form (TFA or acetate) is documented. Optional tests include water content by Karl Fischer, acetate content, and endotoxin. These values appear together on the certificate of analysis.
How should a peptide sequence be written?
Write the sequence from the N-terminus on the left to the C-terminus on the right, the standard convention matching synthesis and biological reading direction. Use either single-letter or three-letter amino acid codes consistently. Note terminal modifications explicitly: H- or a free amine indicates an unmodified N-terminus, Ac- indicates acetylation, -OH indicates a free C-terminal acid, and -NH2 indicates amidation. For example, Ac-AGCKNFFWKTFTSC-NH2 specifies an acetylated N-terminus and amidated C-terminus.
How should research peptides be stored for chemical stability?
Store lyophilized peptides desiccated at -20 C or colder, protected from light and moisture, where they are stable for extended periods. In solution, peptides degrade faster, so prepare working stocks fresh and freeze unused portions in single-use aliquots to avoid repeated freeze-thaw cycles. Sequences containing cysteine, methionine, or tryptophan are prone to oxidation, and Asn or Gln residues can deamidate, so these are especially sensitive. Allow vials to reach room temperature before opening to prevent condensation.
Create a free research account to view current pricing, real-time stock, and bundles, then submit your order for approval.
More research peptide questions
How to Order and Buy Research Peptides: Ordering FAQ · Shipping and Delivery Questions · Purity, Testing, and Certificates of Analysis (COA) · Peptide Reconstitution and Research Dosing Math: Reference FAQ · Research Peptide Storage, Handling, and Shelf Life · Research Peptide Legality, Regulations, and Research-Use Compliance
All questions & answers · What are peptides? · Research guides · Order portal